Ancora Advisors’s Harvard Bioscience HBIO Stock Holding History

Ancora Advisors’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,149	Closed	-$650K	–	1342
2018 Q2	$650K	Sell	12,149 -2,761	-19%	-$141K	0.03%	424
2018 Q1	$745K	Sell	14,910 -5,186	-26%	-$232K	0.03%	388
2017 Q4	$663K	Buy	20,096 +968	+5%	+$32.7K	0.04%	375
2017 Q3	$717K	Buy	19,128 +3,570	+23%	+$106K	0.04%	386
2017 Q2	$397K	Buy	15,558 +5,038	+48%	+$125K	0.03%	462
2017 Q1	$274K	Buy	+10,520	New	+$303K	0.02%	525

Other funds holding HBIO

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Ancora Advisors's HBIO Position: Q3 2018 in Review

Ancora Advisors sold out of Harvard Bioscience (HBIO) in Q3 2018, closing a stake of 12,149 shares — an estimated $650K sold.

Ancora Advisors first reported a position in HBIO in Q1 2017 and held it in 6 quarters. The position peaked at $745K in Q1 2018. 94 funds tracked by Wall St. Rank hold HBIO as of Q3 2018.

Ancora Advisors reported no remaining Harvard Bioscience position as of Q3 2018 after selling out during the quarter.
Ancora Advisors sold 12,149 Harvard Bioscience shares in Q3 2018, an estimated $650K.
Ancora Advisors first reported a position in Harvard Bioscience in Q1 2017 and held it in 6 quarters.
Ancora Advisors's Harvard Bioscience position peaked at $745K in Q1 2018.
94 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2018.

Based on Ancora Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.